Progyny, Inc. Announces Details for Its First Quarter 2023 Results Report
Progyny, Inc. (Nasdaq: PGNY) will report its financial results for the quarter ending March 31, 2023, on May 8, 2023, after market close. The company will host a conference call at 4:45 PM ET to discuss these results. Interested participants can access the call by dialing specific numbers provided for U.S. and international participants using the passcode 265484. An audio replay will be available until May 15, 2023. Progyny specializes in fertility benefits management, offering comprehensive solutions that include education, access to specialists, and cost reduction for employers. The company has received recognition from several reputable organizations for its growth and leadership in the healthcare sector.
- Progyny has been recognized by CNBC Disruptor 50 and Modern Healthcare’s Best Places to Work in Healthcare.
- The company aims to reduce healthcare costs for leading employers while driving optimal clinical outcomes.
- None.
NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financial results for the quarterly period ended March 31, 2023 after the close of the market on Monday, May 8, 2023.
The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call.
Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcode.
An audio replay of the call will be available through Monday, May 15, 2023 and may be accessed by dialing 1.800.332.6854 (U.S. participants) or 1.973.528.0005 (international participants) with the passcode 265484.
A live webcast and archive of the call will be available from the Events and Presentations section of the Company’s website at http://investors.progyny.com.
About Progyny
Progyny (Nasdaq: PGNY) is a leading fertility benefits management company. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive solution can simultaneously benefit employers, patients, and physicians.
Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.
Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com
Media:
Selena Yang
media@progyny.com
FAQ
When will Progyny report its Q1 2023 financial results?
What time is the Progyny conference call scheduled for?
What is the passcode for the Progyny conference call?
How can I access the replay of the Progyny conference call?
